Date Title Description PDF
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download

Pages

Date Title Description PDF
01 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 23 February and 29 February 2024 Download
27 Feb 2024 Annual Corporate Governance Report ROVI releases the 2023 Annual Corporate Governance Report Download
27 Feb 2024 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2023 annual report regarding remuneration of the members of the Board of Directors. Download
23 Feb 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 16 February and 22 February 2024 Download
16 Feb 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 9 February and 15 February 2024 Download

Pages

Date Title Description PDF
27 Feb 2014 Informe anual de remuneraciones de consejeros 2013 Download
27 Nov 2013 Acuerdos estratégicos con terceros Download
26 Nov 2013 Acuerdos estratégicos con terceros Download
07 Nov 2013 Información sobre resultados (4) Download
07 Nov 2013 Información sobre resultados (3) Download

Pages